World's Best Scientists 2026 revealed!
Bruce G. Robinson

Bruce G. Robinson

D-Index & Metrics

Medicine

D-Index
97
Citations
54055
World Ranking
9086
National Ranking
273

Overview

Bruce G. Robinson is an academic affiliated with the University of Sydney in Australia. Their primary field of research is Medicine, with a particular focus on Endocrinology, Diabetes and Metabolism. Additional subfields of study include Oncology, Surgery, Pulmonary and Respiratory Medicine, and Epidemiology.

The scientist's work concentrates mainly on thyroid cancer diagnosis and treatment, alongside related areas such as cancer-related molecular pathways, pituitary gland disorders and treatments, neuroendocrine tumor research advances, lung cancer treatments and mutations, adrenal and paraganglionic tumors, and BRCA gene mutations in cancer.

Robinson's recent papers reflect significant research topics and publication in respected venues:

  • RET Solvent Front Mutations Mediate Acquired Resistance to Selective RET Inhibition in RET-Driven Malignancies, 2020, Journal of Thoracic Oncology
  • Phase 3 Trial of Selpercatinib in Advanced RET -Mutant Medullary Thyroid Cancer, 2023, New England Journal of Medicine
  • A Proposed Grading Scheme for Medullary Thyroid Carcinoma Based on Proliferative Activity (Ki-67 and Mitotic Count) and Coagulative Necrosis, 2020, The American Journal of Surgical Pathology
  • Medullary Thyroid Cancer: Updates and Challenges, 2023, Endocrine Reviews
  • Multikinase inhibitors in thyroid cancer: timing of targeted therapy, 2021, Nature Reviews Endocrinology

Frequent collaborators in their research include the following co-authors:

  • Roderick Clifton-Bligh
  • Matti L. Gild
  • Anthony Glover
  • Venessa Tsang
  • Mark Sywak

Robinson's work is published frequently in venues such as Endocrine Related Cancer, Endocrinology Diabetes and Metabolism Case Reports, Endocrine Oncology, Journal of Thoracic Oncology, and the New England Journal of Medicine.

Best Publications

  • Intensive versus conventional glucose control in critically ill patients.

    Nice-Sugar Study Investigators;D. Chittock;S. Su;D. Blair

  • US Renal Data System 2018 Annual Data Report: Epidemiology of Kidney Disease in the United States.

    Rajiv Saran;Bruce Robinson;Kevin C. Abbott;Lawrence Y.C. Agodoa

  • US Renal Data System 2015 Annual Data Report: Epidemiology of Kidney Disease in the United States.

    Rajiv Saran;Yi Li;Bruce Robinson;Kevin C. Abbott

  • US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States

    Rajiv Saran;Yi Li;Bruce Robinson;John Ayanian

  • Revised American thyroid association guidelines for the management of medullary thyroid carcinoma

    Samuel A Wells;Sylvia L Asa;Henning Dralle;Rossella Elisei

  • Lenvatinib versus placebo in radioiodine-refractory thyroid cancer.

    Martin Schlumberger;Makoto Tahara;Lori J. Wirth;Bruce Robinson

  • Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial

    Samuel A. Wells;Bruce G. Robinson;Robert F. Gagel;Henning Dralle

  • The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis.

    Charis Eng;Charis Eng;David Clayton;Isabelle Schuffenecker;Gilbert Lenoir

  • Hypoglycemia and risk of death in critically ill patients.

    Simon R Finfer;Bette Liu;Dean R Chittock;Robyn Norton

  • Mutation Spectrum and Genotype-Phenotype Analyses in Cowden Disease and Bannayan-Zonana Syndrome, Two Hamartoma Syndromes With Germline PTEN Mutation

    Debbie J. Marsh;Valérie Coulon;Kathryn L. Lunetta;Philippe Rocca-Serra

  • HRPT2, encoding parafibromin, is mutated in hyperparathyroidism–jaw tumor syndrome

    J.D. Carpten;C.M. Robbins;A. Villablanca;L. Forsberg

  • Clinical presentation and penetrance of Pheochromocytoma/ Paraganglioma syndromes.

    Diana E. Benn;Anne Paule Gimenez-Roqueplo;Jennifer R. Reilly;Jérôme Bertherat

  • Efficacy of Selpercatinib in RET-Altered Thyroid Cancers

    Lori J Wirth;Eric Sherman;Bruce Robinson;Benjamin Solomon

  • A HIF1α Regulatory Loop Links Hypoxia and Mitochondrial Signals in Pheochromocytomas

    Patricia L. M. Dahia;Ken N Ross;Matthew E Wright;Cesar Y. Hayashida

  • Differential Nuclear and Cytoplasmic Expression of PTEN in Normal Thyroid Tissue, and Benign and Malignant Epithelial Thyroid Tumors

    Oliver Gimm;Aurel Perren;Aurel Perren;Liang-Ping Weng;Debbie J. Marsh;Debbie J. Marsh

  • HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours

    V M Howell;C J Haven;K Kahnoski;S K Khoo

  • Somatic mutations in the RET proto-oncogene in sporadic medullary thyroid carcinoma.

    Debbie J. Marsh;Diana L. Learoyd;Diana L. Learoyd;Scott D. Andrew;Lalitha Krishnan

  • Characterization and gestational regulation of corticotropin-releasing hormone messenger RNA in human placenta.

    D M Frim;R L Emanuel;B G Robinson;C M Smas

  • Multiple Endocrine Neoplasia Type 2 and Familial Medullary Thyroid Carcinoma: An Update

    Samuel A. Wells;Furio Pacini;Bruce G. Robinson;Massimo Santoro

  • US Renal Data System 2016 Annual Data Report: Epidemiology of Kidney Disease in the United States (vol 69, pg s7, 2017)

    Rajiv Saran;Bruce Robinson;Kevin C Abbott;Lawrence Yc Agodoa

Frequent Co-Authors

Anthony J. Gill
Anthony J. Gill University of Sydney
Ronald L. Pisoni
Ronald L. Pisoni Arbor Research Collaborative for Health
Charis Eng
Charis Eng Cleveland Clinic Lerner College of Medicine
Steven I. Sherman
Steven I. Sherman The University of Texas MD Anderson Cancer Center
Friedrich K. Port
Friedrich K. Port University of Michigan–Ann Arbor
Hal Morgenstern
Hal Morgenstern University of Michigan–Ann Arbor
Rossella Elisei
Rossella Elisei University of Pisa
Martin Schlumberger
Martin Schlumberger University of Paris-Saclay
Bin Tean Teh
Bin Tean Teh National University of Singapore
Henning Dralle
Henning Dralle University of Duisburg-Essen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Online healthcare programs offer flexible options for those looking to advance their medical education or begin a new career. Many students interested in healthcare explore advanced practice degrees, such as the dnp online programs, which can be completed from home while balancing other commitments.

For those seeking a smoother academic journey, easiest online dnp programs are designed to streamline coursework and provide support, making it accessible for busy professionals. Alternatively, individuals aiming to enter the workforce quickly may consider a 6 month lpn program online, allowing students to become licensed practical nurses in a short period of time.

Mental health careers are also in demand, and the shortest pmhnp program can prepare Registered Nurses to become Psychiatric Mental Health Nurse Practitioners, ready to make a difference in patients’ lives faster than traditional routes. Exploring these related pathways can provide flexible and rewarding career options in the evolving field of healthcare.

Best Scientists Citing Bruce G. Robinson

Trending Scientists